Worldwide Clinical Trials Executive and Leadership Team

Daniel Gizachew, the Chief Executive Officer at Worldwide Clinical Trials, directs the overarching strategic vision for the global contract research organization. By overseeing the integration of preclinical and Phase I-IV clinical development services, the Chief Executive Officer ensures alignment across all therapeutic areas including Cardiovascular, Metabolic, and Neuroscience. Daniel Gizachew drives the expansion of bioanalytical sciences to support complex biotechnology and pharmaceutical programs. This leadership role involves managing high-level partnerships and maintaining the competitive market position of the firm within the international research landscape. Through the optimization of late-phase studies and real-world evidence initiatives, the Chief Executive Officer secures long-term growth and operational efficiency. By fostering a culture of scientific rigor, the Chief Executive Officer guides the company toward achieving critical milestones in drug development. Ultimately, the Chief Executive Officer maintains the reputation of the firm as a premier partner for global clinical research.

Keya Watkins, the President, Oncology at Worldwide Clinical Trials, directs the specialized research strategy for the oncology therapeutic division. By overseeing the design and execution of complex oncology clinical trials, the President, Oncology ensures that biotechnology and pharmaceutical clients receive high-performing development services. Keya Watkins drives the expansion of the oncology portfolio by leveraging advanced clinical methodologies and real-world evidence. This leadership role involves collaborating with global medical teams to address the unique challenges of cancer research and patient recruitment. By optimizing the clinical trial lifecycle, the President, Oncology accelerates the path to market for innovative oncology therapies. The President, Oncology also manages the strategic relationships with key stakeholders to maintain the leadership position of the firm in the oncology sector. Through the application of deep therapeutic expertise, the President, Oncology ensures that every study meets the highest standards of scientific integrity and regulatory success.

Lisa Skorets, the Chief of Staff, Gcd at Worldwide Clinical Trials, coordinates cross-functional operations to streamline clinical development workflows. By managing internal communications and executive priorities, the Chief of Staff, Gcd ensures that the organization executes complex Phase I-IV projects with precision. Lisa Skorets facilitates collaboration between departments to support the delivery of high-quality bioanalytical and clinical services. This role involves monitoring operational performance metrics to drive efficiency across the global footprint of the firm. By aligning departmental goals with the broader mission of the company, the Chief of Staff, Gcd optimizes resource allocation for diverse therapeutic programs. The Chief of Staff, Gcd also manages the implementation of strategic initiatives that enhance the service delivery model for pharmaceutical clients. Through meticulous oversight of internal processes, the Chief of Staff, Gcd supports the seamless execution of clinical trials from early-phase research through post-approval studies.

Joy Clark, the Chief People Officer at Worldwide Clinical Trials, architects the human capital strategy to attract and retain top-tier scientific talent. By overseeing global recruitment, professional development, and organizational culture, the Chief People Officer ensures the workforce possesses the expertise required for complex clinical development services. Joy Clark drives initiatives that promote employee engagement and operational excellence across the international offices of the firm. This leadership role involves designing compensation structures and performance management systems that align with the growth objectives of the company. By fostering an inclusive environment, the Chief People Officer supports the diverse teams working on Cardiovascular, Metabolic, and Rare Disease research. Joy Clark also manages the integration of talent during organizational scaling to maintain high standards of service delivery. Through the implementation of robust training programs, the Chief People Officer ensures the staff remains at the forefront of clinical research methodologies and regulatory compliance.